Papargyriou, Aristeidis https://orcid.org/0000-0002-2577-4737
Najajreh, Mulham
Cook, David P.
Maurer, Carlo H.
Bärthel, Stefanie https://orcid.org/0000-0001-5986-4864
Messal, Hendrik A. https://orcid.org/0000-0003-2259-0286
Ravichandran, Sakthi K.
Richter, Till https://orcid.org/0000-0001-6008-8209
Knolle, Moritz
Metzler, Thomas https://orcid.org/0000-0002-1620-5559
Shastri, Akul R.
Öllinger, Rupert
Jasper, Jacob
Schmidleitner, Laura
Wang, Surui
Schneeweis, Christian
Ishikawa-Ankerhold, Hellen
Engleitner, Thomas
Mataite, Laura
Semina, Mariia
Trabulssi, Hussein
Lange, Sebastian https://orcid.org/0000-0003-0406-1401
Ravichandra, Aashreya
Schuster, Maximilian https://orcid.org/0000-0001-9030-2210
Mueller, Sebastian https://orcid.org/0009-0008-1514-3027
Peschke, Katja
Schäfer, Arlett https://orcid.org/0000-0002-8010-594X
Dobiasch, Sophie
Combs, Stephanie E.
Schmid, Roland M.
Bausch, Andreas R. https://orcid.org/0000-0002-4608-9544
Braren, Rickmer
Heid, Irina
Scheel, Christina H.
Schneider, Günter https://orcid.org/0000-0003-1840-4508
Zeigerer, Anja
Luecken, Malte D.
Steiger, Katja https://orcid.org/0000-0002-7269-5433
Kaissis, Georgios https://orcid.org/0000-0001-8382-8062
van Rheenen, Jacco https://orcid.org/0000-0001-8175-1647
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Saur, Dieter https://orcid.org/0000-0001-5874-0210
Rad, Roland https://orcid.org/0000-0002-6849-9659
Reichert, Maximilian https://orcid.org/0000-0002-8611-5639
Article History
Received: 1 March 2023
Accepted: 26 September 2024
First Online: 10 December 2024
Competing interests
: M.L. was a contractor for the Chan Zuckerberg Initiative and received speaker fees from Pfizer and Janssen Pharmaceuticals. F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd, Cellarity and Omniscope, and has ownership interest in Dermagnostix GmbH and Cellarity. The other authors declare no competing interests.